Abstracts

Patient Outcomes In Those Diagnosed With Multiple Myeloma Over A 5-Year Period In India

Introduction:Multiple myeloma (MM) is the second most common hematological malignancy worldwide. The treatment of MM is induction therapy followed by an autologous stem cell transplant (A...

Ahmed Salih ;

Sasmith R. Menakuru ;

Amir F. Beirat ;

Vijaypal Dhillon ;

11/04/2022

Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update

Introduction:

Lorenzo Falchi ;

Kim M. Linton ;

Aqeel Abbas ;

Brian Elliott ;

David Belada ;

Joshua Brody ;

Yasmin Karimi ;

Raul Cordoba ;

Sylvia Snauwaert ;

Jun Wu ;

Liwei Wang ;

Michael Roost Clausen ;

Fritz Offner ;

11/04/2022

End-of-treatment PET in Early-stage Hodgkin lymphoma: Valuable in Addition to Interim-PET

Introduction:Recent clinical trials have demonstrated the prognostic importance of the F18-fluorodeoxyglucose interim-PET scan in early-stage classical Hodgkin lymphoma (HL); however, the...

Bradford Hoppe ;

Patrick B. Johnston ;

Ivana N. Micallef ;

Thomas M. Habermann , MD;

Stephen Ansell ;

Karan Chohan ;

Jason R. Young ;

Scott Lester ;

Muhammad A. Moustafa ;

Allison Rosenthal ;

Han W. Tun ;

11/04/2022

Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Introduction:Multiple Myeloma (MM) cells show resistance to standard therapies due to overexpression of the transport protein, Exportin 1. Selinexor is a novel drug that targets the Expor...

Maham Babar ;

Madeeha S. Waleed ;

Arslan Inayat ;

Danish Safi ;

Anum Babar ;

Hina Zubair ;

Mainoma Bano ;

Sana Rafique ;

Arzu Shahid ;

11/04/2022

Diffuse Large B-Cell Lymphoma with Leptomeningeal Disease: Role for High-Dose Intravenous Methotrexate

Introduction:

Jason Y. Chang ;

Man K. Ho ;

Kamila Bakirhan ;

11/04/2022

Efficacy and Safety of Denosumab in Patients with Multiple Myeloma

#REF!

Grifi Fatiha ;

Bougherira Soraya ;

11/04/2022

Treatment History in Castleman Disease. A Real-world Case Series from Italian Tertiary Referral Centres

Introduction:

Fabiana Esposito ;

Amalia Figuera ;

Filippo Gherlinzoni ;

Federica Librale ;

Maurizio Miglino ;

Ricardo Marcolin ;

Chiara Pagani ;

Caterina Plenteda ;

Livio Pupo ;

Simone Ragaini ;

Viot M. Rapisarda ;

Piero M. Stefani ;

Alessandro Broccoli ;

Annaguila Zizzari ;

Lucia Anemona ;

Simone Ferrero ;

Ricardo Bruna ;

Maria Cantonetti ;

11/04/2022

Myeloid Sarcoma: A Retrospective Analysis in a General Community Hospital

Introduction:

Zheng J. Lin , MS;

Kok-Hoy Chan ;

Adan Rios ;

Benoy Yohannan ;

11/04/2022

Treatment Dilemma in Hodgkin‚Äôs Lymphoma with Fulminant Hepatic Failure

Introduction:Classical Hodgkin‚Äôs Lymphoma (cHL) presenting as cholestatic or obstructive jaundice often has a complicated clinical course. The cause of jaundice can be attributed to cHL...

Kok-Hoy Chan ;

Adan Rios ;

11/04/2022

Magrolimab in Combination With Rituximab in Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 3-Year Follow-up Results From a Phase 1/2 Trial

Introduction:

Ian W. Flinn ;

Nancy L. Bartlett , MD;

Amitkumar Mehta ;

Nilanjan Ghosh , MD, PhD;

Leslie Popplewell ;

Carol O'Hear ;

Yanan Huo ;